MAM
IDYA icon

Meeder Asset Management’s IDEAYA Biosciences IDYA Stock Holding History

Meeder Asset Management’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.36K Buy
251
+123
+96% +$4.13K ﹤0.01% 736
2025
Q4 		$4.42K Buy
+128
New +$4.08K ﹤0.01% 808
2025
Q3 		– Sell
-136
Closed -$2.86K – 870
2025
Q2 		$2.86K Sell
136
-39
-22% -$748 ﹤0.01% 783
2025
Q1 		$2.87K Sell
175
-4
-2% -$85 ﹤0.01% 837
2024
Q4 		$4.6K Buy
179
+55
+44% +$1.56K ﹤0.01% 842
2024
Q3 		$3.93K Buy
124
+26
+27% +$986 ﹤0.01% 778
2024
Q2 		$3.44K Buy
+98
New +$3.88K ﹤0.01% 813

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Meeder Asset Management's IDYA Position: Q1 2026 in Review

Meeder Asset Management increased its IDEAYA Biosciences (IDYA) stake by 96% in Q1 2026, buying an estimated $4.13K and bringing the position to 251 shares worth $8.36K. The position accounts for ﹤0.01% of the portfolio, ranked #736.

Meeder Asset Management first reported a position in IDYA in Q2 2024 and has held it in 7 quarters since. 253 funds tracked by Wall St. Rank hold IDYA as of Q1 2026.

  • Meeder Asset Management held 251 shares of IDEAYA Biosciences worth $8.36K as of Q1 2026.
  • Meeder Asset Management bought 123 IDEAYA Biosciences shares in Q1 2026, an estimated $4.13K.
  • IDEAYA Biosciences made up ﹤0.01% of Meeder Asset Management's portfolio in Q1 2026, its #736 holding.
  • Meeder Asset Management first reported a position in IDEAYA Biosciences in Q2 2024 and has held it in 7 quarters since.
  • 253 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q1 2026.

Based on Meeder Asset Management's 13F filing for Q1 2026, filed 7 May 2026.